1
|
Ostrom QT, Gittleman H, Farah P, Ondracek
A, Chen Y, Wolinsky Y, Stroup NE, Kruchko C and Barnholtz-Sloan JS:
CBTRUS statistical report: Primary brain and central nervous system
tumors diagnosed in the United States in 2006–2010. Neuro Oncol.
15(Suppl 2): ii1–ii56. 2013. View Article : Google Scholar :
|
2
|
Stupp R, Brada M, van den Bent MJ, Tonn JC
and Pentheroudakis G: High-grade glioma: ESMO clinical practice
guidelines for diagnosis, treatment and follow-up. Ann Oncol.
25(Suppl 3): iii93–iii101. 2014. View Article : Google Scholar : PubMed/NCBI
|
3
|
Stupp R, Tonn JC, Brada M and
Pentheroudakis G: High-grade malignant glioma: ESMO clinical
practice guidelines for diagnosis, treatment and follow-up. Ann
Oncol. 21(Suppl 5): v190–v193. 2010. View Article : Google Scholar : PubMed/NCBI
|
4
|
Demuth T and Berens ME: Molecular
mechanisms of glioma cell migration and invasion. J Neurooncol.
70:217–228. 2004. View Article : Google Scholar
|
5
|
Mrugala MM, Adair J and Kiem HP:
Temozolomide: Expanding its role in brain cancer. Drugs Today
(Barc). 46:833–846. 2010. View Article : Google Scholar
|
6
|
Anai M, Shojima N, Katagiri H, Ogihara T,
Sakoda H, Onishi Y, Ono H, Fujishiro M, Fukushima Y, Horike N, et
al: A novel protein kinase B (PKB)/AKT-binding protein enhances PKB
kinase activity and regulates DNA synthesis. J Biol Chem.
280:18525–18535. 2005. View Article : Google Scholar : PubMed/NCBI
|
7
|
Enomoto A, Murakami H, Asai N, Morone N,
Watanabe T, Kawai K, Murakumo Y, Usukura J, Kaibuchi K, Takahashi
M, et al: Akt/PKB regulates actin organization and cell motility
via Girdin/APE. Dev Cell. 9:389–402. 2005. View Article : Google Scholar : PubMed/NCBI
|
8
|
Ohara K, Enomoto A, Kato T, Hashimoto T,
Isotani-Sakakibara M, Asai N, Ishida-Takagishi M, Weng L, Nakayama
M, Watanabe T, et al: Involvement of Girdin in the determination of
cell polarity during cell migration. PLoS One. 7:e366812012.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Kitamura T, Asai N, Enomoto A, Maeda K,
Kato T, Ishida M, Jiang P, Watanabe T, Usukura J, Kondo T, et al:
Regulation of VEGF-mediated angiogenesis by the Akt/PKB substrate
Girdin. Nat Cell Biol. 10:329–337. 2008. View Article : Google Scholar : PubMed/NCBI
|
10
|
Miyake H, Maeda K, Asai N, Shibata R,
Ichimiya H, Isotani-Sakakibara M, Yamamura Y, Kato K, Enomoto A,
Takahashi M and Murohara T: The actin-binding protein Girdin and
its Akt-mediated phosphorylation regulate neointima formation after
vascular injury. Circ Res. 108:1170–1179. 2011. View Article : Google Scholar : PubMed/NCBI
|
11
|
Garcia-Marcos M, Jung BH, Ear J, Cabrera
B, Carethers JM and Ghosh P: Expression of GIV/Girdin, a
metastasis-related protein, predicts patient survival in colon
cancer. FASEB J. 25:590–599. 2011. View Article : Google Scholar :
|
12
|
Jiang P, Enomoto A, Jijiwa M, Kato T,
Hasegawa T, Ishida M, Sato T, Asai N, Murakumo Y and Takahashi M:
An actin-binding protein Girdin regulates the motility of breast
cancer cells. Cancer Res. 68:1310–1318. 2008. View Article : Google Scholar : PubMed/NCBI
|
13
|
Garcia-Marcos M, Ear J, Farquhar MG and
Ghosh P: A GDI (AGS3) and a GEF (GIV) regulate autophagy by
balancing G protein activity and growth factor signals. Mol Biol
Cell. 22:673–686. 2011. View Article : Google Scholar : PubMed/NCBI
|
14
|
Zhao L, Ma S, Liu Q and Liang P: Clinical
implications of Girdin protein expression in glioma.
ScientificWorldJournal. 2013:9860732013. View Article : Google Scholar : PubMed/NCBI
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2 (-Delta Delta C (T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
16
|
Natsume A, Kato T, Kinjo S, Kato T,
Hasegawa T, Ishida M, Sato T, Asai N, Murakumo Y, Takahashi M and
Wakabayashi T: Girdin maintains the stemness of glioblastoma stem
cells. Oncogene. 31:2715–2724. 2012. View Article : Google Scholar
|
17
|
Cao K, Jiang W, Cao P, Zou Q, Xiao S, Zhou
J and Huang C: Talen-mediated girdin knockout downregulates cell
proliferation, migration and invasion in human esophageal carcinoma
ECA109 cells. Mol Med Rep. 10:848–854. 2014.PubMed/NCBI
|
18
|
Gu F, Wang L, He J, Liu X, Zhang H, Li W,
Fu L and Ma Y: Girdin, an actin-binding protein, is critical for
migration, adhesion and invasion of human glioblastoma cells. J
Neurochem. 131:457–469. 2014. View Article : Google Scholar : PubMed/NCBI
|
19
|
Zhang B, Gu F, She C, Guo H, Li W, Niu R,
Fu L, Zhang N and Ma Y: Reduction of Akt2 inhibits migration and
invasion of glioma cells. Int J Cancer. 125:585–595. 2009.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Liu W, Bagaitkar J and Watabe K: Roles of
AKT signal in breast cancer. Front Biosci. 12:4011–4019. 2007.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Nicholson KM and Anderson NG: The protein
kinase B/Akt signalling pathway in human malignancy. Cell Signal.
14:381–395. 2002. View Article : Google Scholar : PubMed/NCBI
|
22
|
Ghosh P, Garcia-Marcos M, Bornheimer SJ
and Farquhar MG: Activation of Galphai3 triggers cell migration via
regulation of GIV. J Cell Biol. 182:381–393. 2008. View Article : Google Scholar : PubMed/NCBI
|
23
|
Lin C, Ear J, Pavlova Y, Mittal Y,
Kufareva I, Ghassemian M, Abagyan R, Garcia-Marcos M and Ghosh P:
Tyrosine phosphorylation of the Galpha-interacting protein GIV
promotes activation of phosphoinositide 3-kinase during cell
migration. Sci Signal. 4:ra642011.
|